Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same
AssigneeNastech Pharmaceutical Company Inc.
InventorJeffrey Wenig
Life of this patent
Estimating the term…
Abstract
Invention relates to nasal administration of known anti-nausea and anti-emetic therapeutic agents and dosage forms useful for such administration.
Claims9
A method of eliciting a systemic, therapeutic, antihistaminic, antinausea or antiemetic response in a mammal which comprises nasal administration to said mammal of a systemically, therapeutically effective antihistaminic antinausea or antiemetic amount of a therapeutic agent selected from the group consisting of cyclizine, chlorcyclizine, meclizine, buclizine, trimethobenzamide and benzquinamide or a pharmaceutically acceptable acid addition salt thereof together with a pharmaceutically acceptable nasal carrier therefor.
A pharmaceutically acceptable composition for nasal administration in the form of a nasal solution, suspension, ointment or gel to obtain a systemic, therapeutic, antihistaminic antinausea or antiemetic response in a mammal comprising a systemically, therapeutically effective amount of an antihistaminic, antinausea or antiemetic therapeutic agent selected from the group consisting of cyclizine, chlorcyclizine, meclizine, buclizine, trimethobenzamide and benzquinamide or a pharmaceutically acceptable acid addition salt thereof together with a pharmaceutically acceptable nasal carrier therefor.
Dependencies are inferred from the claim text.